相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional Antibodies Targeting IsaA of Staphylococcus aureus Augment Host Immune Response and Open New Perspectives for Antibacterial Therapy
Udo Lorenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice
Ichiro Inoshima et al.
NATURE MEDICINE (2011)
Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli
Eduardo L. Lopez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
Michael Z. David et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury
Georgia A. Wilke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates
Leonard E. Weisman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia
Brook E. Ragle et al.
INFECTION AND IMMUNITY (2009)
Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults
Leonard E. Weisman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Raxibacumab for the Treatment of Inhalational Anthrax.
Thi-Sau Migone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Staphylococcus aureus α-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic Cells
Robin R. Craven et al.
PLOS ONE (2009)
A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use
K. S. Wagner et al.
VACCINE (2009)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
α-Toxin Facilitates the Generation of CXC Chemokine Gradients and Stimulates Neutrophil Homing in Staphylococcus aureus Pneumonia
Allison H. Bartlett et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Poring over pores:: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
NATURE MEDICINE (2007)
Human botulism immune globulin for the treatment of infant botulism
SS Arnon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Antibacterial drug discovery: is it all downhill from here?
SJ Projan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A
AE Hall et al.
INFECTION AND IMMUNITY (2003)
The abandonment of antibacterials: why and wherefore?
DM Shlaes
CURRENT OPINION IN PHARMACOLOGY (2003)
Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus
SJ Peacock et al.
INFECTION AND IMMUNITY (2002)
分享论文
